This compound is primarily utilized in the pharmaceutical and biotechnology industries as a key intermediate in the synthesis of complex molecules, particularly those targeting neurological and psychiatric disorders. Its unique structure, featuring both amino and fluoro groups, makes it valuable for developing drugs that interact with specific receptors in the brain, such as adrenergic or dopaminergic receptors. Additionally, the presence of the iodophenyl group allows for further functionalization, enabling the creation of radiolabeled compounds for use in positron emission tomography (PET) imaging. This aids in the study and diagnosis of neurological conditions by providing insights into receptor distribution and activity in the brain.